BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 42 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $13,444,000 | +261.6% | 13,428,000 | +283.7% | 0.29% | +178.1% |
Q1 2020 | $3,718,000 | -74.6% | 3,500,000 | -73.3% | 0.10% | -21.1% |
Q4 2018 | $14,628,000 | -11.5% | 13,120,000 | -4.4% | 0.13% | -40.1% |
Q3 2018 | $16,527,000 | +177.9% | 13,720,000 | +174.4% | 0.22% | +167.5% |
Q2 2018 | $5,947,000 | -80.7% | 5,000,000 | -80.7% | 0.08% | -82.8% |
Q4 2017 | $30,822,000 | +153.8% | 25,915,000 | +159.2% | 0.48% | +166.9% |
Q3 2017 | $12,142,000 | +103.5% | 10,000,000 | +100.0% | 0.18% | +84.7% |
Q2 2017 | $5,968,000 | -83.1% | 5,000,000 | -78.4% | 0.10% | -73.7% |
Q1 2015 | $35,265,000 | -59.8% | 23,188,000 | -67.7% | 0.37% | -60.3% |
Q4 2014 | $87,691,000 | +18.8% | 71,763,000 | +7.4% | 0.94% | -23.4% |
Q3 2014 | $73,802,000 | +4.8% | 66,800,000 | 0.0% | 1.22% | -0.3% |
Q2 2014 | $70,446,000 | +0.1% | 66,800,000 | +6.0% | 1.23% | -7.6% |
Q1 2014 | $70,357,000 | +73.6% | 63,045,000 | +68.1% | 1.33% | +78.3% |
Q4 2013 | $40,523,000 | – | 37,500,000 | – | 0.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonora Investment Management, LLC | 6,195,000 | $9,377,000 | 2.84% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $10,750,000 | 1.09% |
Man Investments (CH) AG | 1,100,000 | $1,482,000 | 0.73% |
ADVENT CAPITAL MANAGEMENT /DE/ | 22,554,000 | $30,444,000 | 0.47% |
SSI INVESTMENT MANAGEMENT LLC | 3,124,000 | $4,202,000 | 0.45% |
ARROWGRASS CAPITAL PARTNERS (US) LP | 20,000 | $22,373,000 | 0.42% |
Calamos Advisors LLC | 35,219,000 | $47,628,000 | 0.33% |
LINDEN ADVISORS LP | 2,500,000 | $3,370,000 | 0.23% |
Calamos Wealth Management LLC | 513,000 | $694,000 | 0.17% |
LOOMIS SAYLES & CO L P | 477,810 | $50,323,000 | 0.15% |